A Phase 2 Study of Bortezomib Plus High-Dose Melphalan (Mel/Vel) Conditioning for Autologous Hematopoietic Cell Transplantation In Multiple Myeloma,
Year: 2011
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Taiga Nishihori, Leonel Ochoa, Joseph Pidala, Kenneth H. Shain, Rachid Baz, Christine Simonelli, Dan Sullivan, Claudio Anasetti, Melissa Alsina
Institution: Moffitt Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2534071436